SecSonar.com

Ensysce Biosciences, Inc. (ENSC)

Ensysce Biosciences, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Ensysce Biosciences, Inc. (ENSC) is a Biotechnology company based in US with a market capitalization of $2.6M. Revenue declined 2.8% year-over-year and free cash flow was negative at -$7.8T. This page tracks ENSC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 7 employees · IPO Mar 14, 2018

Valuation

Valuation & price

$0.28 · as of May 17, 2026 · -89.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.00

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.57$1.41$0.25Jul 25Dec 25Jul 26Jul 7, 25$2.31Jul 9, 25$2.24Jul 11, 25$2.16Jul 15, 25$2.11Jul 17, 25$2.16Jul 21, 25$2.17Jul 23, 25$2.23Jul 25, 25$2.24Jul 29, 25$2.20Jul 31, 25$2.09Aug 4, 25$2.15Aug 6, 25$2.12Aug 11, 25$2.08Aug 13, 25$2.15Aug 15, 25$2.05Aug 19, 25$2.03Aug 21, 25$2.07Aug 25, 25$2.05Aug 27, 25$2.08Aug 29, 25$2.09Sep 3, 25$2.17Sep 5, 25$2.13Sep 9, 25$2.12Sep 11, 25$2.13Sep 16, 25$2.11Sep 18, 25$2.10Sep 22, 25$2.19Sep 24, 25$2.23Sep 26, 25$2.24Sep 30, 25$2.37Oct 2, 25$2.45Oct 6, 25$2.43Oct 8, 25$2.46Oct 10, 25$2.25Oct 14, 25$2.47Oct 16, 25$2.57Oct 21, 25$2.32Oct 23, 25$2.11Oct 27, 25$2.14Oct 29, 25$2.09Oct 31, 25$2.18Nov 4, 25$2.08Nov 6, 25$2.07Nov 10, 25$2.03Nov 12, 25$2.06Nov 14, 25$2.06Nov 18, 25$1.93Nov 20, 25$1.61Nov 25, 25$1.70Nov 28, 25$1.77Dec 2, 25$1.57Dec 4, 25$1.63Dec 8, 25$1.60Dec 10, 25$1.58Dec 12, 25$1.43Dec 16, 25$1.18Dec 18, 25$1.14Dec 22, 25$1.18Dec 24, 25$1.11Dec 29, 25$1.01Jan 2, 26$0.94Jan 6, 26$1.01Jan 8, 26$1.06Jan 12, 26$0.91Jan 14, 26$0.93Jan 16, 26$0.84Jan 21, 26$0.92Jan 23, 26$0.86Jan 27, 26$0.85Jan 29, 26$0.72Feb 2, 26$0.71Feb 4, 26$0.57Feb 9, 26$0.61Feb 11, 26$0.41Feb 13, 26$0.43Feb 18, 26$0.39Feb 20, 26$0.40Feb 24, 26$0.39Feb 26, 26$0.40Mar 2, 26$0.60Mar 4, 26$0.50Mar 6, 26$0.55Mar 10, 26$0.49Mar 12, 26$0.43Mar 17, 26$0.47Mar 19, 26$0.57Mar 23, 26$0.59Mar 25, 26$0.56Mar 27, 26$0.53Mar 31, 26$0.54Apr 2, 26$0.61Apr 7, 26$0.58Apr 9, 26$0.48Apr 13, 26$0.55Apr 15, 26$0.54Apr 17, 26$0.50Apr 22, 26$0.43Apr 24, 26$0.41Apr 28, 26$0.38Apr 30, 26$0.37May 4, 26$0.42May 6, 26$0.39May 8, 26$0.35May 12, 26$0.32May 14, 26$0.28May 18, 26$0.32May 20, 26$0.31May 22, 26$0.32May 28, 26$0.30Jun 1, 26$0.28Jun 3, 26$0.27Jun 5, 26$0.25Jun 9, 26$0.25Jun 11, 26$0.26Jun 15, 26$0.27Jun 17, 26$0.27Jun 22, 26$0.27Jun 24, 26$0.28Jun 26, 26$0.30Jul 2, 26$0.28
$0.2552-week range$2.57
Loading valuation history…

Fundamentals

Key fundamentals

$2.6M

Market cap

-2.8%

Revenue growth (YoY)

0.0%

Gross margin

-$7.8T

Free cash flow (USD)

-$4T

Net debt

Net cash position

46.4%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$0.00FY 2018$0.00FY 2019$1.8MFY 2020$3.9MFY 2021$3.5MFY 2022$2.5MFY 2023$2.2MFY 2024$5.2MFY 2025$5.1M
$0$5.1M

Free cash flow by year

2017 → 2025

FY 2017$-251.8KFY 2018$-1.2MFY 2019$11.0MFY 2020$-1.2MFY 2021$-8.2MFY 2022$-17.9MFY 2023$-10.8MFY 2024$-7502.7BFY 2025$-7806.3B
-$251.8K-$7.8T

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022-686.1%FY 2023-240.1%FY 2024-38.6%FY 20250.0%
100.0%0.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-0.52)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • FinancingSecurities RegistrationJun 4, 2026Filing
  • 8-K eventDelisting NoticeMay 22, 2026Filing
  • 8-K eventQ1 2026 Financial ResultsMay 15, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing
  • FinancingSecurities RegistrationApr 9, 2026Filing
  • 8-K eventCommon Stock Purchase WarrantApr 8, 2026Filing
  • 8-K eventDirector ResignationApr 3, 2026Filing

Questions

Frequently asked questions

What is Ensysce Biosciences, Inc.'s market cap?

Ensysce Biosciences, Inc. (ENSC) has a market capitalization of $2.6M.

What is ENSC's P/E ratio?

A meaningful P/E ratio is not available for ENSC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ENSC's price-to-book (P/B) ratio?

ENSC trades at 0.00 times book value per share.

When did Ensysce Biosciences, Inc. last report earnings?

ENSC last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying ENSC stock?

SEC Form 4 filings show no open-market insider buys at Ensysce Biosciences, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

INM

InMed Pharmaceuticals Inc.

$2.9M

AZTR

Azitra, Inc.

$2.3M

GOVX

GeoVax Labs, Inc.

$2M

ELAB

PMGC Holdings Inc.

$3.4M

ERNA

Ernexa Therapeutics Inc.

$3.4M

VIVS

VivoSim Labs, Inc.

$3.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.